EUVIMEDEUVIMED entdecken
Crossref

Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway

Qi Chen, Jiayu Guo, Shangting Han, Tianyu Wang, Kang Xia, Bo Yu, Yifan Lu, Tao Qiu, Jiangqiao Zhou

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Qi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan University ,Wuhan, Hubei 430060, China; Department of Urology, Renmin…. Hauptthemen laut MEDLINE: Reperfusion Injury, Deoxyadenosines, Kidney, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal ischemia-reperfusion injury (IRI) makes a significant contribution to delayed graft function (DGF) and reduced allograft survival time post-transplantation, thereby complicating the prognosis of renal transplant recipients. Cordycepin, an active compound purified from the traditional Chinese medicine Cordyceps sinensis, has exhibited remarkable anti-inflammatory and organ-protective effects against various diseases, including neurological, hepatic, and metabolic disorders. Therefore, the present study used a murine model of renal ischemia/reperfusion (I/R) and HK2 cell line hypoxia/reoxygenation (H/R) to determine whether cordycepin influences renal IRI. The findings indicated that cordycepin significantly mitigated renal IRI by inhibiting the p38/JNK signaling pathway in the renal tubular epithelial cells, thereby suppressing inflammation, cell apoptosis, and ferroptosis. These findings offer a novel avenue for improving the prognosis of renal transplant recipients and allograft survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryDeoxyadenosinesKidneyAnti-Inflammatory AgentsAnimalsHumansCell LineMaleMiceKidney Transplantationp38 Mitogen-Activated Protein KinasesApoptosisMAP Kinase Signaling SystemMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

CordycepinFerroptosisInflammationKidney ischemia reperfusion injuryTraditional Chinese medicine

Substanzen

cordycepinDeoxyadenosinesp38 Mitogen-Activated Protein KinasesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan University ,Wuhan, Hubei 430060, China; Department of Urology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430060,…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Q., Guo, J., Han, S., Wang, T., Xia, K., Yu, B., Lu, Y., Qiu, T., & Zhou, J. (2025). Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114264

Vancouver

Chen Q, Guo J, Han S, Wang T, Xia K, Yu B, et al. Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114264

BibTeX
@article{Chen2025,
  author = {Chen, Qi and Guo, Jiayu and Han, Shangting and Wang, Tianyu and Xia, Kang and Yu, Bo and Lu, Yifan and Qiu, Tao and Zhou, Jiangqiao},
  title = {Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114264}
}
Kostenlos starten →